← FDA DRUG APPROVALS
FDA NDA · NDA021735
TERCONAZOLE VAGINAL CREAM 0.8%
terconazole
Sponsor: FOUGERA PHARMS INC
APPLICATION
NDA021735
TYPE
NDA
ORIGINAL APPROVAL
2004-10-01
LATEST ACTION
2025-08-22
ROUTE
VAGINAL
DOSAGE FORM
CREAM
MARKETING STATUS
Prescription
Products
TERCONAZOLE · ReferencePrescription
TERCONAZOLE 0.8% · CREAM · VAGINAL
Approval history
2013-01-16Manufacturing (CMC) · Supplement 5 · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.